These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22546385)

  • 61. Why not partial nephrectomy?
    Navai N; Ramos P; Zhao LC; Meeks JJ; Nadler RB; Smith ND
    Urology; 2008 Aug; 72(2):243-6. PubMed ID: 18584853
    [No Abstract]   [Full Text] [Related]  

  • 62. Re: comparison of laparoendoscopic single-site radical nephrectomy with conventional laparoscopic radical nephrectomy for localized renal-cell carcinoma.
    Cadeddu JA
    J Urol; 2011 Jan; 185(1):97-8. PubMed ID: 22082912
    [No Abstract]   [Full Text] [Related]  

  • 63. [Laparoscopic radical nephrectomy].
    Sanchez de Badajoz E
    Arch Esp Urol; 2004 Dec; 57(10):1137. PubMed ID: 15714855
    [No Abstract]   [Full Text] [Related]  

  • 64. Partial nephrectomy for renal cell carcinoma: trust suturing.
    Janetschek G
    J Endourol; 2008 Sep; 22(9):1933-5; discussion 1943. PubMed ID: 18811496
    [No Abstract]   [Full Text] [Related]  

  • 65. Re: Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?
    Taneja SS
    J Urol; 2011 Apr; 185(4):1225-6. PubMed ID: 22098955
    [No Abstract]   [Full Text] [Related]  

  • 66. Editorial comment.
    White WM; Derweesh IH
    Urology; 2013 Jun; 81(6):1230-1. PubMed ID: 23541440
    [No Abstract]   [Full Text] [Related]  

  • 67. Editorial Comment to Spherical cap surface model: A novel method for predicting renal function after partial nephrectomy.
    Hutchinson R; Margulis V
    Int J Urol; 2016 Aug; 23(8):673. PubMed ID: 27458706
    [No Abstract]   [Full Text] [Related]  

  • 68. [Nephron sparing surgery for renal cell carcinoma].
    Faris G; Stein A; Lurie A
    Harefuah; 1996 Nov; 131(10):438-40. PubMed ID: 8981826
    [No Abstract]   [Full Text] [Related]  

  • 69. Editorial Comment from Dr Kadono to Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy.
    Kadono Y
    Int J Urol; 2020 Jul; 27(7):623-624. PubMed ID: 32452086
    [No Abstract]   [Full Text] [Related]  

  • 70. Conservative vs radical surgery for renal cell carcinoma.
    Van Poppel H
    BJU Int; 2004 Oct; 94(6):766-8. PubMed ID: 15476505
    [No Abstract]   [Full Text] [Related]  

  • 71. Editorial comment for Chu et al.
    Nadler RB
    J Endourol; 2015 Apr; 29(4):400. PubMed ID: 25531132
    [No Abstract]   [Full Text] [Related]  

  • 72. Partial nephrectomy for renal cell carcinoma in an allograft kidney 15 years after transplantation.
    Kim JY; Ruckle HC; Ramin SA
    J Urol; 2001 Apr; 165(4):1205. PubMed ID: 11257674
    [No Abstract]   [Full Text] [Related]  

  • 73. Editorial comment on: Results of endoluminal occlusion of the inferior vena cava during radical nephrectomy and thrombectomy.
    Kirkali Z
    Eur Urol; 2008 Oct; 54(4):783-4. PubMed ID: 18524465
    [No Abstract]   [Full Text] [Related]  

  • 74. For: Radical nephrectomy in the setting of metastatic renal cell cancer: proceed judiciously.
    Aron M; Gill IS
    J Urol; 2009 Sep; 182(3):832-3. PubMed ID: 19643447
    [No Abstract]   [Full Text] [Related]  

  • 75. Open partial nephrectomy for renal tumours: current status.
    Novick AC; Derweesh I
    BJU Int; 2005 Mar; 95 Suppl 2():35-40. PubMed ID: 15720333
    [No Abstract]   [Full Text] [Related]  

  • 76. [Analysis of safety and efficacy of laparoscopic and open partial nephrectomy for small renal cell carcinoma].
    Yao K; Zhou LQ; Li XS; Song Y; Li NC; He ZS
    Zhonghua Wai Ke Za Zhi; 2010 Mar; 48(5):372-4. PubMed ID: 20450611
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Editorial Comment to Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma.
    Teishima J
    Int J Urol; 2020 Aug; 27(8):662. PubMed ID: 32578259
    [No Abstract]   [Full Text] [Related]  

  • 78. Editorial comment.
    Fonseca F
    Int Braz J Urol; 2015; 41(4):704-6. PubMed ID: 26668858
    [No Abstract]   [Full Text] [Related]  

  • 79. Editorial Comment to Systemic therapy in the management of localized and locally advanced renal cell carcinoma: Current state and future perspectives.
    Tatsugami K
    Int J Urol; 2019 May; 26(5):542-543. PubMed ID: 30943577
    [No Abstract]   [Full Text] [Related]  

  • 80. Editorial Comment from Dr Koie et al. to Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy.
    Koie T; Nakane K; Iinuma K
    Int J Urol; 2020 Jul; 27(7):623. PubMed ID: 32495385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.